NEO.NASDAQNeogenomics INC

SCHEDULE: Greenhouse Funds Discloses 7.1% Stake in NeoGenomics

Sentiment:

Schedule 13G Amendment


Greenhouse Funds LLLP and associated parties have filed an amendment reporting a 7.1% beneficial ownership stake in NeoGenomics, Inc.

Summary

  • Greenhouse Funds LLLP, Greenhouse GP LLC, and Joseph Milano filed a Schedule 13G amendment.
  • The reporting persons collectively beneficially own 9,215,903 shares of NeoGenomics, Inc. common stock.
  • This holding represents 7.1% of the company's outstanding common stock.
  • The shares are held on behalf of advisory clients of Greenhouse Funds, LLLP.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure regarding institutional shareholding changes, which does not inherently signal a change in company fundamentals.

Positives

  • Institutional interest from Greenhouse Funds indicates confidence in the company's long-term prospects.
  • The filing confirms that the stake was acquired in the ordinary course of business, not for the purpose of changing or influencing control.

Negatives

  • None identified in this regulatory disclosure.

Risks

  • The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest, which is standard but highlights the nature of investment management holdings.

Future Outlook

The filing does not provide forward-looking guidance for the company, as it is a disclosure of beneficial ownership.

Industry Context

StockSavvy.ai notes that institutional filings of this nature are common in the healthcare and diagnostics sector, reflecting ongoing portfolio rebalancing by investment firms.

Comparison to Industry Standards

  • The filing adheres to standard SEC requirements for reporting beneficial ownership exceeding 5% under Rule 13d-1.
  • The disclosure of shared voting and dispositive power is consistent with standard investment advisory practices.

Stakeholder Impact

  • Shareholders may view the 7.1% stake as a sign of institutional support for the company's current strategic direction.

Next Steps

  • Continued monitoring of future SEC filings for changes in institutional ownership positions.

Key Dates

DateDescription
03/31/2026Date of event which requires filing of this statement.
05/15/2026Date of the Schedule 13G Amendment filing.

Keywords

NeoGenomics, Schedule 13G, Institutional Ownership, Greenhouse Funds, Common Stock, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.